← FDA Drug Approvals (Drugs@FDA)

ZILXI

NDA · New Drug Application · Sponsor: JOURNEY · Approved 2020-05-28

Drug application

FDA Application #

NDA213690

Application type

New Drug Application

Brand name

ZILXI

Generic name

MINOCYCLINE

Active ingredients

MINOCYCLINE HYDROCHLORIDE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

JOURNEY

Manufacturer

Journey Medical Corporation

First approval

2020-05-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown